<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24769243</PMID><DateCompleted><Year>2015</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-9096</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Antiviral research</Title><ISOAbbreviation>Antiviral Res</ISOAbbreviation></Journal><ArticleTitle>Inhibition of enterovirus 71 infection by antisense octaguanidinium dendrimer-conjugated morpholino oligomers.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>41</EndPage><MedlinePgn>35-41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.antiviral.2014.04.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0166-3542(14)00110-7</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV-71) infections are generally manifested as mild hand, foot and mouth disease, but have been reported to cause severe neurological complications with high mortality rates. Treatment options remain limited due to the lack of antivirals. Octaguanidinium-conjugated morpholino oligomers (vivo-MOs) are single-stranded DNA-like antisense agents that can readily penetrate cells and reduce gene expression by steric blocking of complementary RNA sequences. In this study, inhibitory effects of three vivo-MOs that are complementary to the EV-71 internal ribosome entry site (IRES) and the RNA-dependent RNA polymerase (RdRP) were tested in RD cells. Vivo-MO-1 and vivo-MO-2 targeting the EV-71 IRES showed significant viral plaque reductions of 2.5 and 3.5 log10PFU/ml, respectively. Both vivo-MOs reduced viral RNA copies and viral capsid expression in RD cells in a dose-dependent manner. In contrast, vivo-MO-3 targeting the EV-71 RdRP exhibited less antiviral activity. Both vivo-MO-1 and 2 remained active when administered either 4h before or within 6h after EV-71 infection. Vivo-MO-2 exhibited antiviral activities against poliovirus (PV) and coxsackievirus A16 but vivo-MO-1 showed no antiviral activities against PV. Both the IRES-targeting vivo-MO-1 and vivo-MO-2 inhibit EV-71 RNA translation. Resistant mutants arose after serial passages in the presence of vivo-MO-1, but none were isolated against vivo-MO-2. A single T to C substitution at nucleotide position 533 was sufficient to confer resistance to vivo-MO-1. Our findings suggest that IRES-targeting vivo-MOs are good antiviral candidates for treating early EV-71 infection, and vivo-MO-2 is a more favorable candidate with broader antiviral spectrum against enteroviruses and are refractory to antiviral resistance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Chee Wah</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yoke Fun</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia; Tropical Infectious Disease Research and Education Center, University of Malaya, 50603 Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quah</LastName><ForeName>Yi Wan</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Faculty of Science and Technology, Sunway University, 46150 Petaling Jaya, Selangor, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poh</LastName><ForeName>Chit Laa</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Faculty of Science and Technology, Sunway University, 46150 Petaling Jaya, Selangor, Malaysia. Electronic address: pohcl@sunway.edu.my.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Antiviral Res</MedlineTA><NlmUniqueID>8109699</NlmUniqueID><ISSNLinking>0166-3542</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050091">Dendrimers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D060172">Morpholinos</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050091" MajorTopicYN="N">Dendrimers</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060172" MajorTopicYN="N">Morpholinos</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012692" MajorTopicYN="N">Serial Passage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010948" MajorTopicYN="N">Viral Plaque Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antiviral agent</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Hand, foot and mouth disease</Keyword><Keyword MajorTopicYN="N">Morpholino oligomers</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>4</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>1</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>4</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24769243</ArticleId><ArticleId IdType="pmc">PMC7118997</ArticleId><ArticleId IdType="doi">10.1016/j.antiviral.2014.04.004</ArticleId><ArticleId IdType="pii">S0166-3542(14)00110-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arita M., Wakita T., Shimizu H. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J. Gen. Virol. 2008;89:2518&#x2013;2530.</Citation><ArticleIdList><ArticleId IdType="pubmed">18796721</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsham G.J. Divergent picornavirus IRES elements. Virus Res. 2009;139:183&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">18675861</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong P., Hsieh S.Y., Liu C.C., Chou A.H., Chang J.Y., Wu S.C., Liu S.J., Chow Y.H., Su I.J., Klein M. Production of EV71 vaccine candidates. Hum. Vaccine Immunother. 2012;8:1775&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656065</ArticleId><ArticleId IdType="pubmed">22992566</ArticleId></ArticleIdList></Reference><Reference><Citation>de Smet M.D., Meenken C.J., van den Horn G.J. Fomivirsen &#x2013; a phosphorothioate oligonucleotide for the treatment of CMV retinitis. Ocul. Immunol. Inflamm. 1999;7:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">10611727</ArticleId></ArticleIdList></Reference><Reference><Citation>Deas T.S., Binduga-Gajewska I., Tilgner M., Ren P., Stein D.A., Moulton H.M., Iversen P.L., Kauffman E.B., Kramer L.D., Shi P.Y. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J. Virol. 2005;79:4599&#x2013;4609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1069577</ArticleId><ArticleId IdType="pubmed">15795246</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J.X., Nie X.J., Lei Y.F., Ma C.F., Xu D.L., Li B., Xu Z.K., Zhang G.C. The highly conserved 5&#x2019; untranslated region as an effective target towards the inhibition of enterovirus 71 replication by unmodified and appropriate 2&#x2019;-modified siRNAs. J. Biomed. Sci. 2012;19:73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3438048</ArticleId><ArticleId IdType="pubmed">22889374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias N., Stein C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002;1:347&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">12489851</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Q., Pastey M., Kobasa D., Puthavathana P., Lupfer C., Bestwick R.K., Iversen P.L., Chen J., Stein D.A. Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers. Antimicrob. Agents Chemother. 2006;50:3724&#x2013;3733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1635187</ArticleId><ArticleId IdType="pubmed">16966399</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinney R.M., Huang C.Y., Rose B.C., Kroeker A.D., Dreher T.W., Iversen P.L., Stein D.A. Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers. J. Virol. 2005;79:5116&#x2013;5128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1069583</ArticleId><ArticleId IdType="pubmed">15795296</ArticleId></ArticleIdList></Reference><Reference><Citation>Kole R., Krainer A.R., Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov. 2012;11:125&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743652</ArticleId><ArticleId IdType="pubmed">22262036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Li M.L., Shih S.R. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009;37:47&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2615614</ArticleId><ArticleId IdType="pubmed">19010963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J.Y., Shih S.R., Pan M., Li C., Lue C.F., Stollar V., Li M.L. HnRNP A1 interacts with the 5&#x2019; untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J. Virol. 2009;83:6106&#x2013;6114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2687368</ArticleId><ArticleId IdType="pubmed">19339352</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerdyk-Schauwecker M., Stein D.A., Eide K., Blouch R.E., Bildfell R., Iversen P., Jin L. Inhibition of herpes simplex virus 1 ocular infection with morpholino oligomers targeting ICP0 and ICP27. Antiviral Res. 2009;84:131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">19665486</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton J.D., Jiang S. Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules. 2009;14:1304&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6253989</ArticleId><ArticleId IdType="pubmed">19325525</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman B.W., Stein D.A., Kroeker A.D., Paulino A.D., Moulton H.M., Iversen P.L., Buchmeier M.J. Antisense morpholino-oligomers directed against the 5&#x2019; end of the genome inhibit coronavirus proliferation and growth. J. Virol. 2004;78:5891&#x2013;5899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC415795</ArticleId><ArticleId IdType="pubmed">15140987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Opriessnig T., Patel D., Wang R., Halbur P.G., Meng X.J., Stein D.A., Zhang Y.J. Inhibition of porcine reproductive and respiratory syndrome virus infection in piglets by a peptide-conjugated morpholino oligomer. Antiviral Res. 2011;91:36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">21554902</ArticleId></ArticleIdList></Reference><Reference><Citation>Paessler S., Rijnbrand R., Stein D.A., Ni H., Yun N.E., Dziuba N., Borisevich V., Seregin A., Ma Y., Blouch R., Iversen P.L., Zacks M.A. Inhibition of alphavirus infection in cell culture and in mice with antisense morpholino oligomers. Virology. 2008;376:357&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447162</ArticleId><ArticleId IdType="pubmed">18468653</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D., Opriessnig T., Stein D.A., Halbur P.G., Meng X.J., Iversen P.L., Zhang Y.J. Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication. Antiviral Res. 2008;77:95&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114306</ArticleId><ArticleId IdType="pubmed">17959259</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang B., Deng C., Ye H., Xu W., Yuan Z., Shi P.Y., Zhang B. Development and characterization of a stable eGFP enterovirus 71 for antiviral screening. Antiviral Res. 2013;97:198&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">23267829</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L., Xu M., Yin Z. Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res. 2013;97:183&#x2013;194.</Citation><ArticleIdList><ArticleId IdType="pubmed">23261847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.R., Stollar V., Li M.L. Host factors in enterovirus 71 replication. J. Virol. 2011;85:9658&#x2013;9666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196451</ArticleId><ArticleId IdType="pubmed">21715481</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.R., Tsai M.C., Tseng S.N., Won K.F., Shia K.S., Li W.T., Chern J.H., Chen G.W., Lee C.C., Lee Y.C., Peng K.C., Chao Y.S. Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone. Antimicrob. Agents Chemother. 2004;48:3523&#x2013;3529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC514779</ArticleId><ArticleId IdType="pubmed">15328120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim A.C., Luhur A., Tan T.M., Chow V.T., Poh C.L. RNA interference against enterovirus 71 infection. Virology. 2005;341:72&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">16083932</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone J.K., Rijnbrand R., Stein D.A., Ma Y., Yang Y., Iversen P.L., Andino R. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. Antimicrob. Agents Chemother. 2008;52:1970&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2415775</ArticleId><ArticleId IdType="pubmed">18347107</ArticleId></ArticleIdList></Reference><Reference><Citation>Summerton J. Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim. Biophys. Acta. 1999;1489:141&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">10807004</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Chan Y.F. Enterovirus 71 receptors: promising drug targets? Expert Rev. Anti Infect. Ther. 2013;11:547&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pubmed">23750725</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Chan Y.F., Sim K.M., Tan E.L., Poh C.L. Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1. PLoS One. 2012;7:e34589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3341398</ArticleId><ArticleId IdType="pubmed">22563456</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Lai J.K.F., Sam I.C., Chan Y.F. Recent developments in antiviral agents against enterovirus 71 infection. J. Biomed. Sci. 2014;21:14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3924904</ArticleId><ArticleId IdType="pubmed">24521134</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Poh C.L., Sam I.C., Chan Y.F. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013;87:611&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan E.L., Tan T.M., Chow V.T., Poh C.L. Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71. Antiviral Res. 2007;74:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">17316836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan E.L., Tan T.M., Tak Kwong Chow V., Poh C.L. Inhibition of enterovirus 71 in virus-infected mice by RNA interference. Mol. Ther. 2007;15:1931&#x2013;1938.</Citation><ArticleIdList><ArticleId IdType="pubmed">17712333</ArticleId></ArticleIdList></Reference><Reference><Citation>Vagnozzi A., Stein D.A., Iversen P.L., Rieder E. Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers. J. Virol. 2007;81:11669&#x2013;11680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2168802</ArticleId><ArticleId IdType="pubmed">17728223</ArticleId></ArticleIdList></Reference><Reference><Citation>Warfield K.L., Swenson D.L., Olinger G.G., Nichols D.K., Pratt W.D., Blouch R., Stein D.A., Aman M.J., Iversen P.L., Bavari S. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog. 2006;2:e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1326218</ArticleId><ArticleId IdType="pubmed">16415982</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren T.K., Shurtleff A.C., Bavari S. Advanced morpholino oligomers: a novel approach to antiviral therapy. Antiviral Res. 2012;94:80&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114334</ArticleId><ArticleId IdType="pubmed">22353544</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., Yang F., Zhao R., Zhao L., Guo D., Jin Q. Identification of small interfering RNAs which inhibit the replication of several enterovirus 71 strains in China. J. Virol. Methods. 2009;159:233&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">19490979</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh M.T., Wang S.W., Yu C.K., Lin K.H., Lei H.Y., Su I.J., Wang J.R. A single nucleotide in stem loop II of 5&#x2019;-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS One. 2011;6:e27082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3206083</ArticleId><ArticleId IdType="pubmed">22069490</ArticleId></ArticleIdList></Reference><Reference><Citation>Youngblood D.S., Hatlevig S.A., Hassinger J.N., Iversen P.L., Moulton H.M. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Bioconjug. Chem. 2007;18:50&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17226957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Stein D.A., Lim T., Qiu D., Coughlin S., Liu Z., Wang Y., Blouch R., Moulton H.M., Iversen P.L., Yang D. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site. J. Virol. 2006;80:11510&#x2013;11519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1642606</ArticleId><ArticleId IdType="pubmed">16987987</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Dong H., Stein D.A., Shi P.Y. Co-selection of West Nile virus nucleotides that confer resistance to an antisense oligomer while maintaining long-distance RNA/RNA base pairings. Virology. 2008;382:98&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202013</ArticleId><ArticleId IdType="pubmed">18842280</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>